Heads up for anyone who likes a good bargain: Exicure’s stock just jumped 40% after their new stem cell drug helped almost every patient hit their treatment goal—fast. The big deal? Patients could get their cells collected the same day, making life a lot easier for folks facing tough transplants. Traders are buzzing that the stock’s still cheap, even after the pop. If you like a comeback story, keep an eye on this one! #Business #Market #stocks